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Doppler Studies Can Predict Long-Term
Outcome of Growth-Restricted Fetuses
Susumu Miyashita and Yoshihide Chiba
Objectives: To evaluate measures related to adverse long-term outcomes of
growth-restricted fetuses, and to compare their clinical efficacies.
Methods: One hundred and nineteen growth-restricted fetuses were examined
prospectively. All fetuses were singletons and free from any morphologic anomaly
or abnormal karyotype. Standardized estimated fetal body weight (EFBWdSD),
nonstress test, contraction stress test, standardized resistance index of the umbilical
artery (UmA) and middle cerebral artery, pH of fetal blood (sampled by cordocentesis)
and oligohydramnios were all analyzed. All fetuses were delivered within 10 days
after fetal blood sampling and were monitored for at least 3 years after birth. All
findings were recorded cross-sectionally and analyzed by logistic regression modeling.
Results: Sixteen fetuses showed adverse outcomes including neonatal death,
infantile death, cerebral palsy and/or developmental retardation. UmA-standardized
resistance index (RIdSD) ≥ +4.0 and fetal blood pH < 7.32 were independent
variables for adverse outcomes. The adjusted odds ratios (95% confidence interval)
for these factors were 16.8 (3.23–87.0) and 7.76 (1.55–39.0), respectively.
Conclusions: UmA-RIdSD and fetal blood pH are readily available independent
predictors of adverse long-term outcome of intrauterine growth-restricted fetuses.
(J Med Ultrasound 2002;10:86–93)
KEY WORDS: • Doppler imaging • fetal growth restriction • outcome • ultrasound
Received: March 21, 2002. Accepted: April 25, 2002.
Department of Perinatology, National Cardiovascular Center, Osaka.
Address correspondence and reprint requests to: Dr. S. Miyashita, Department of Perinatology, National Cardiovascular
Center, 5-7-1 Fujishirodai, Suita City, Osaka, 565-8565 Japan.
INTRODUCTION
There is little evidence to support the nonstress test
(NST), contraction stress test (CST), Doppler flow
studies or estimation of amniotic fluid volume for
predicting the outcomes of preterm, growth-restricted
human fetuses. The relationship between fetal
asphyxia and neonatal outcome appears to be
established in fetuses with normal growth [1, 2].
Nonetheless, useful predictors for adverse outcomes
of growth-restricted fetuses that differentiate “sick,
small” fetuses remain controversial [3, 4]. It is not
possible to predict when best to deliver preterm,
growth-restricted fetuses, and this cannot be resolved
without data for long-term outcomes of these fetuses.
The purpose of the present study was to clarify
which measures can predict adverse long-term
outcomes of growth-restricted fetuses.
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PATIENTS AND METHODS
We studied 119 growth-restricted singleton fetuses
at the Department of Perinatology of the National
Cardiovascular Center between 1988 and 1999. The
diagnosis of “growth restriction” was made when
at least one measurement showed that the estimated
fetal body weight (EFBW) was less than –1.5 SD
between the 24th and 36th weeks of gestation [5].
Some fetuses were catching up in growth when the
examinations were performed. These measurements
were not excluded to limit the examination to delivery
time interval (delivery within 10 days after
examination).
The presence of oligohydramnios was confirmed
if the amniotic fluid index was 5 cm or less. All
fetuses were morphologically and karyotypically
normal. Gestational age was confirmed by measure-
ment of crown-rump length in the early weeks of
pregnancy in all cases. Figure 1 shows the distri-
bution of EFBW and causes of growth restriction
for the gestational week. The cause of growth
restriction could not be determined in most cases.
The series of examinations was carried out within
24 hours in all cases (Figure 2). Some of these
fetuses were subjects of our preliminary study [6].
All fetuses had thorough Doppler imaging
examinations. We used ultrasound (Toshiba SSH-
65A, Toshiba SSA-270A, Toshiba SSA-260A and
Toshiba SSA-340A, Tokyo, Japan) for velocimetry
of the umbilical artery (UmA) and middle cerebral
artery (MCA) in the pulsed Doppler mode. The
angle of the Doppler beam transmission to the blood
flow was less than 60 degrees in all measurements.
Doppler waveform by fast Fourier transformation
was consecutively recorded for five cardiac cycles
when fetal gross movement, fetal breathing move-
ment or uterine contractions were not observed. The
mean value of the systolic peak velocity (S) and the
end-diastolic velocity (D) in these cycles were used
in the following equation: RI = (S-D)/S (RI =
resistance index). We also calculated the standard-
ized RI (RIdSD): dSD = (m-M)/SD (m = measured
value of gestational age, M = mean value of gesta-
tional age, SD = standard deviation of gestational
age) to exclude change with gestational age. The
control nomograms for UmA-RI and MCA-RI were
made from the findings of normal growth fetuses
Fig. 1. Gestational week (GW), estimated body weight and suspected causes of fetal growth restriction. SD =
standard deviation for GW on the nomogram.
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without anomalies, chromosomal abnormalities or
maternal complications.
We ensured that all fetuses went through NST.
Fetal heart rate (FHR) was monitored for 20 minutes,
and when acceleration was not observed during the
first 20 minutes, monitoring was continued for another
20 minutes, for a total of 40 minutes. Our definition
of acceleration was a temporal increase in FHR of
at least 15 bpm in fetuses after the 30th week of
gestation, or at least 10 bpm in those before the 30th
week, that lasted for 15 seconds or more. NST
results were recorded as “reactive” when one episode
of acceleration or more was observed during FHR
monitoring for 20 minutes (or 40 minutes). A result
of “non-reactive” was recorded when we observed
no acceleration in FHR after 40 minutes of
monitoring.
Fetal blood sampling was carried out before CST
in the first 61 fetuses, but after CST in the 58
remaining fetuses. The CSTs were obtained while
mothers were on intravenous oxytocin, except in
five cases. The initial dose of oxytocin infusion was
1 mIU/minute. This was gradually increased until
regular uterine contractions were achieved
(~ three contractions in 10 min). The findings of
CST were recorded as positive when uniform late
decelerations or mixed patterns (variable decelerations
with late components) were greater than 50% for
at least 10 regular contractions. They were recorded
as negative when no deceleration or variable
decelerations without late components were observed.
The results were recorded as equivocal when late
decelerations or the mixed pattern were not uniform
or were less than 50% for the uterine contractions.
The CST finding was also recorded as equivocal
when late decelerations due to excessively strong
uterine contractions were observed. Umbilical ve-
nous blood was sampled by cordocentesis with
ultrasound guidance under local or epidural anesthesia
in all cases. The blood gases were analyzed imme-
diately using an ABL 300 blood gas analyzer
(Radiometer, Copenhagen, Denmark) or 280 blood
gas analyzer (CIBA-Corning, Emeryville, CA, USA).
We also measured the MCV (mean red cell volume)
to exclude missampling of maternal blood.
We decided on the mode of delivery based on
the CST findings in the earlier 61 cases, but on the
findings of fetal blood pH in the remaining 58 cases.
Fig. 2. Clinical course of fetuses in the examination series. C/S = cesarean section.
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The cut-off point of fetal pH 7.318 was selected
based on the CST to achieve the highest sensitivity
and specificity for acidosis of growth-restricted
fetuses [6]. We performed an immediate cesarean
section because of continuous bradycardia after blood
sampling in five fetuses (thus, CST could not be
completed in these cases). Cesarean sections were
performed for nine fetuses with positive CSTs and
decreased fetal blood pH (pH ≤ 7.318). All fetuses
were delivered within 10 days after fetal blood
sampling and monitored for at least 3 years after
birth at our hospital.
All findings were recorded prospectively and
cross-sectionally. Analyzed prenatal measures in-
cluded standardized EFBW (EFBWdSD), results of
NST, CST, UmA-RIdSD, MCA-RIdSD, fetal blood
pH and the presence of oligohydramnios. The lo-
gistic regression models for predicting adverse
outcome were built using these prenatal measures,
which were used as predictor variables with fetal
adverse outcome as the dependent variable. The
findings of NST, CST and the presence of oligo-
hydramnios were used as discrete variables. The
findings of CST were classified into two categories;
1) negative or equivocal; and 2) positive or bradycardia
(CST was not performed in five fetuses because of
immediate cesarean delivery). EFBW-dSD, UmA-
RIdSD, MCA-RIdSD and fetal blood pH were treated
as continuous variables. Nonetheless, some cut-off
values, every 0.5 dSD for EFBW, UmA-RI and
MCA-RI, and every 0.1 pH unit for fetal blood pH,
were also used to make clinical use easier. In this
case, the parameters were treated as discrete variables.
The odds ratios (ORs) with 95% confidence inter-
vals (CIs), which were estimated from the regression
model (not from the actual number of the exami-
nation results), were used as the measures of the
association between prenatal measures and outcomes.
Multivariate logistic regression analysis was used to
provide adjusted relative risk that estimated for the
association between prenatal measures and adverse
outcomes. The analyses were performed using the
statistical software package SPSS for Windows 9.0
(SPSS Inc. Chicage, IL, USA).
RESULTS
Sixteen fetuses had adverse outcomes. There were
three cases of neonatal death, five cases of infantile
death, five cases of cerebral palsy and developmental
Fig. 3. Gestational week (GW), estimated fetal body weight and fetal outcomes. SD = standard deviation for GW on
the nomogram.
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retardation and three cases of developmental retar-
dation only. No fetus died in utero. Figure 3 shows
the distribution of EFBW and the outcome of the
fetuses.
ORs of examination results are presented with
95% CIs in Figure 4, all of which were significant
except for the presence of oligohydramnios. The
ORs of examination results as continuous variables
are also indicated at the bottom of Figure 4, which
shows the relative increases in the ORs with the
change in the factors per unit. For example, UmA-
RI/+1 dSD indicates the relative increase in the OR
when UmA-RI increases by 1 dSD. The ORs of
examination results at specific cut-off points are
shown in Table 1. These cut-off points were chosen
so that the results would have the highest diagnostic
accuracy with statistical significance. Table 2 shows
the actual results of examinations at specific cut-off
Fig. 4. Odds ratios of examination results for adverse outcome of intrauterine growth-restricted fetuses. EFBW =
estimated fetal body weight; UmA = umbilical artery; RI = resistance index; MCA = middle cerebral artery;
NST = non-stress test; CST = contraction stress test; CI = confidence interval.
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points, positive predictive value (PPV), negative
predictive value (NPV) and accuracy for adverse
outcome.
The ORs of the examination results are summa-
rized in Table 1. They cannot be compared with one
another because the mutual relationships among these
factors were not taken into account. The presence
of oligohydramnios was not significant in this
analysis. The stepwise model resulted in a final
logistic regression model that included two variables:
UmA-RIdSD ≥ +4.0 and fetal blood pH ≤ 7.32. The
adjusted ORs are summarized in Table 3.
DISCUSSION
The relationship between FHR monitoring findings
and  the  long- te rm ou tcome of  g rowth-
restricted fetuses remains unclear. The clinical
efficacy of FHR monitoring (NST, CST) for pre-
diction of perinatal morbidity in premature fetuses
[7] and of growth restriction itself [2, 8] has been
reported. Nonetheless, the PPV of the NST for
perinatal compromise is not very high [9], so com-
binations of NST with CST or other examinations,
such as biophysical profile, Doppler studies and fetal
blood sampling might improve diagnostic accuracy
[10] in premature fetuses. There have been few
clinical trials [4, 11] to clarify the significance of
FHR monitoring in subcategories of growth-restricted
fetuses. In the present study, NST had a high NPV
(0.93) for adverse outcome, but the diagnostic
accuracy was relatively low (0.76) because there
were many false-positive cases. The PPV (0.31) for
NST was lower than that of other examinations
(Table 2). The CST also had a high NPV (0.93)
and a higher PPV (0.53), but the diagnostic accuracy
was lower than that of UmA Doppler studies.
Although NST and CST showed a significant re-
lationship to adverse outcome (Table 1), they were
not independent predictors of adverse outcome.
The relationship between Doppler studies and the
long-term outcome of growth-restricted fetuses
remains controversial. Many studies have shown a
very high incidence of adverse outcomes for fetuses
with absent or reverse end-diastolic flow velocity
(AEDV or REDV) of UmAs [12–15]. In the present
study, when UmA-RI was ≥ 1.0, UmA AEDV/
REDV also had a high NPV (0.94), with the highest
diagnostic accuracy (0.93) for adverse outcomes.
UmA-RIdSD ≥ +4.0 also had a high PPV (0.71) for
adverse outcomes in this study. The relation between
fetal cerebral circulation and outcome [16–18] has
also been well documented, and relates to the “brain-
sparing effect” [19, 20]. Fetal blood redistribution
is suggested to be a cerebral vascular response to
poor conditions in utero [21, 22], but the present
results suggested that these responses remain
reversible. We used UmA-RI > MCA-RI as an index
for blood flow redistribution. UmA-RI > MCA-RI
showed the largest number of true-positive cases
(101) and the smallest number of false-negative
cases (2), so the sensitivity (0.88) and NPV (0.97)
were very high. However, the PPV (0.32) and the
diagnostic accuracy (0.73) were relatively low due
to the presence of many false-positive cases.
Fetal blood pH, which was sampled by cordo-
centesis, is direct evidence of the antepartum acid-
base balance, and has been used for the management
Table 1. Odds ratios of examination results for adverse outcome of intrauterine growth-restricted fetuses
Odds ratio* 95% CI p
NST: non-reactive 7.36 2.28 ~ 23.8 0.0008
CST: positive, bradycardia 17.8 5.05 ~ 62.8 < 0.0001
UmA-RIdSD ≥ +4.0 41.3 9.95 ~ 171 < 0.0001
UmA-RI ≥ 1.0 84.1 15.0 ~ 473 < 0.0001
UmA-RI > MCA-RI 33.3 4.21 ~ 263 < 0.0001
MCA-RIdSD < –4.0 5.58 1.67 ~ 18.6 0.0051
EFBWdSD < –3.5 8.17 2.62 ~ 25.5 0.0003
Fetal blood pH < 7.32 17.6 5.01 ~ 61.9 < 0.0001
Oligohydramnios 2.79 0.77 ~ 10.2 0.120
*Calculated from a logistic regression model, not from the actual case numbers shown in Table 2. NST = non-stress test; CST
= contraction stress test; UmA = umbilical artery; RI = resistance index; MCA = middle cerebral artery; EFBW = estimated
fetal body weight; CI = confidence interval.
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of growth-restricted fetuses [23, 24]. However, the
role of fetal blood pH monitoring is limited in
monitoring fetal well-being [21], and the relation
between fetal blood pH and outcome has been
controversial [5]. Its relation to FHR monitoring [25,
286], biophysical profile [27–28] and Doppler stud-
ies [21, 29] has been widely investigated. In the
present study, fetal blood pH < 7.32 had the highest
NPV (0.96), but the PPV (0.44) was lower than that
of Doppler examinations. The diagnostic accuracy
(0.84) for adverse outcomes was nearly equal to that
of CST.
Finally, Doppler study of the UmA and fetal
blood pH were better predictors for adverse out-
comes of growth-restricted fetuses in our study.
Multivariate logistic regression analysis revealed that
UmA-RIdSD ≥ +4.0 and fetal blood pH < 7.32 were
independent predictors of adverse outcome. The
adjusted ORs (16.8, 7.76, respectively) were com-
parable to each other, which quantified the relation
between prenatal examination results and adverse
outcome, excluding a mutual relation among the
analyzed factors. Fetal blood sampling is an invasive
procedure and may be difficult to perform in some
situations. On the other hand, Doppler study of the
UmA is a noninvasive, easy-to-measure predictor for
long-term outcome of growth-restricted fetuses.
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